Holen Sie sich die Stockscreener-App
43.62
1.48%
0.625
Schlusskurs vom Vortag:
$43.00
Offen:
$43.54
24-Stunden-Volumen:
623.14K
Relative Volume:
0.24
Marktkapitalisierung:
$9.01B
Einnahmen:
$2.10B
Nettoeinkommen (Verlust:
$402.17M
KGV:
22.54
EPS:
1.9357
Netto-Cashflow:
$403.87M
1W Leistung:
+4.56%
1M Leistung:
+5.30%
6M Leistung:
-13.44%
1J Leistung:
-11.37%
1-Tages-Spanne:
$43.05
$43.79
1-Wochen-Bereich:
$41.96
$44.41
52-Wochen-Spanne:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Compare QGEN vs TMO, DHR, NTRA, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
43.62 | 8.88B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
601.88 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.66 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
313.57 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
568.24 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.86 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-03-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-22 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen stock steadies after Q2 2026 guidance is reaffirmed - AD HOC NEWS
Qiagen stock gains after Q2 beat and fresh FDA clearance - AD HOC NEWS
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Qiagen N.V. : DZ Bank reiterates its Buy rating - marketscreener.com
Qiagen N.V. (QGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Qiagen Sees Unusually High Options Volume (NYSE:QGEN) - MarketBeat
Goldman Sachs lifts Qiagen voting rights to 2.63% via instruments - Bitget
Qiagen NV (QGEN) Shares Surge 3.7% -- What GF Score of 76 Tells Investors - GuruFocus
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel - Business Wire
QGEN Maintained by Citigroup -- Price Target Raised to $45.00 - GuruFocus
Understanding Qiagen (QGEN) Reliance on International Revenue - Yahoo Finance
Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential With An 8.24% Upside - directorstalkinterviews.com
Qiagen N.V. : Deutsche Bank remains its Buy rating - marketscreener.com
Qiagen NV (QGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company - MarketBeat
Qiagen Q2 Earnings Call Highlights - MarketBeat
QIAGEN Beats Q2 2026 Guidance, Reaffirms Full-Year Outlook Amid Mixed Demand - The Globe and Mail
William Blair Maintains Qiagen NV(QGEN.US) With Hold Rating - 富途牛牛
How Investors Are Reacting To Qiagen (QGEN) Capital Structure Overhaul And US$200 Million Repayment Plan - Sahm
Qiagen NV (QGEN) Stock News Today - TradingKey
Qiagen N.V. Stock 12‑Month Price Target Raised to $44.52, Implies 7% Upside - TradingView
QGEN Maintained by Barclays -- Price Target Raised to $40 - GuruFocus
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen NV (QIA.SG) stock price, news, quote and history - Yahoo Finance UK
QGEN Maintained by JP Morgan -- Price Target Raised to $50 - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $50.00 - MarketBeat
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09 - Moomoo
Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Qiagen N.V. (QGEN) Stock Forecasts - Yahoo Finance
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen N.V. (NYSE: QGEN) Q2 2026 profit, $496.7M synthetic buyback and cash flows - stocktitan.net
QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets - stocktitan.net
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN - MarketBeat
Bank of America Corp DE Sells 418,992 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen (QGEN) Stock Faces An Execution Puzzle After Margin Rebound - Sahm
Qiagen NV (QGEN) (Q2 2026) Earnings Call Highlights: Beats Guida - GuruFocus
Qiagen (NYSE:QGEN) Updates Q3 2026 Earnings Guidance - MarketBeat
Qiagen N.V. : Jefferies reiterates its Buy rating - marketscreener.com
QIAGEN Q2 2026 slides: flat growth masks strong pillar performance - Investing.com
Qiagen: Q2 ahead of expectations; like peers, there's no change to guidance - marketscreener.com
Qiagen NV (0RLT) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Qiagen N.V. 2026 Q2ResultsEarnings Call Presentation (NYSE:QGEN) 2026-08-06 - Seeking Alpha
Q2 2026 Qiagen NV Earnings Call Transcript - GuruFocus
QIAGEN NV : Buy rating from Jefferies - marketscreener.com
QIAGEN NV : Deutsche Bank maintains a Buy rating - marketscreener.com
Qiagen N.V. Q2 2026 Earnings Call Summary - finance.yahoo.com
QIAGEN N.V. (NYSE: QGEN) sets $0.35 dividend and $200M buyback cap - stocktitan.net
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook - BioSpace
QIAGEN N.V. reports results for the quarter ended June 30Earnings Summary - TradingView
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):